Skip to main content
$271.49 -$1.09 (-0.4%)

04:00 PM EDT on 05/30/23

Stryker Corp (NYSE:SYK)

CAPS Rating: 3 out of 5

A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.

Current Price $271.49 Mkt Cap $103.1B
Open $270.98 P/E Ratio 39.51
Prev. Close $271.49 Div. (Yield) $2.89 (1.1%)
Daily Range $270.68 - $275.32 Volume 1,365,798
52-Wk Range $188.84 - $306.56 Avg. Daily Vol. 1,260,214

Caps

How do you think NYSE:SYK will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,376 Outperform
32 Underperform
 

All-Star Players

294 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:SYK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (37.85)
Submitted August 01, 2021

While not a bargain at 29 times this year's midpoint earnings figure of $9.33, SYK isn't expensive either. Analysts estimate that SYK will generate annual earnings growth in the low-teens over the next 5 years, which seems reasonable given the… More

SophicFool (< 20)
Submitted May 21, 2009

With rising unemployment and subsequent loss of health insurance, people are putting off elective hip and knee surgery which adversely affects Stryker.Also, chief executive Stephen MacMillan recently backed off from giving any long term sales and… More

Recent Community Commentary

Read the most recent pitches from players about SYK.

Recs

1
Member Avatar TMFkodyk123 (37.85) Submitted: 7/31/2021 11:53:48 PM : Outperform Start Price: $266.17 NYSE:SYK Score: +6.58

While not a bargain at 29 times this year's midpoint earnings figure of $9.33, SYK isn't expensive either. Analysts estimate that SYK will generate annual earnings growth in the low-teens over the next 5 years, which seems reasonable given the massive backlog of elective procedures stemming from COVID and recent product launches.

Recs

1
Member Avatar Dividends500 (84.01) Submitted: 12/25/2020 8:47:12 AM : Outperform Start Price: $205.42 NYSE:SYK Score: +1.07

Dividends500 tracks the healthiest dividends in the S&P 500.

To qualify for the portfolio, the company must meet three simple requirements:

- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year

Recs

1
Member Avatar R0cketi3 (< 20) Submitted: 10/20/2020 11:26:28 AM : Outperform Start Price: $219.68 NYSE:SYK Score: +1.25

One of the leaders in joint replacement. An area where there is plenty of demand. I'd say pent up demand these days as patients are reluctant to have these procedures.

Leaderboard

Find the members with the highest scoring picks in SYK.

Score Leader

db74006

db74006 (63.97) Score: +493.24

The Score Leader is the player with the highest score across all their picks in SYK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. db74006 63.97 3/23/2009 Outperform NS $26.79 +913.59% +432.78% +480.81 0 Comment
Xitopie < 20 4/3/2009 Outperform 5Y $27.96 +871.08% +405.01% +466.07 1 Comment
saaf569 31.31 3/23/2009 Outperform 3Y $27.06 +903.15% +439.20% +463.95 0 Comment
tpulley 23.66 3/23/2009 Outperform NS $27.06 +903.15% +439.20% +463.95 1 Comment
Moreliator 44.93 3/23/2009 Outperform 3Y $27.32 +893.86% +430.18% +463.68 1 Comment
bejeweledfool < 20 4/6/2009 Outperform 5Y $28.06 +867.58% +409.23% +458.35 0 Comment
MaxPower13 97.91 4/6/2009 Outperform 5Y $27.94 +871.66% +414.17% +457.49 0 Comment
chaddodson 63.06 4/7/2009 Outperform 3Y $27.92 +872.26% +415.67% +456.59 0 Comment
MuhaPSU 95.29 4/7/2009 Outperform 5Y $27.84 +875.20% +420.15% +455.05 0 Comment
chaucersdog 20.75 4/1/2009 Outperform 5Y $27.80 +876.67% +427.17% +449.51 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SYK.